AKT1 and neoplasm: Rescue experiments confirmed the functional reciprocity, wherein MYB overexpression reversed the tumor-suppressive effects of miRNA-195-5p and reactivated PI3K/AKT/mTOR signaling, mirroring the clinical scenario of pathway activation during resistance.